新輔助Pembrolizumab治療早期非小細胞肺癌

Neoadjuvant Pembrolizumab for Early Stage Non-Small Cell Lung Cancer 新輔助Pembrolizumab治療早期非小細胞肺癌 Introduction 介紹 Neoadjuvant immune checkpoint inhibito...[詳細]

Pembrolizumab聯合鉑基化療治療複發性EGFR/

Pembrolizumab in Combination With Platinum-Based Chemotherapy in Recurrent EGFR/ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Pembrolizumab聯合鉑基化療治療複...[詳細]

焦點新聞樣式1

對早期NSCLC關於SBRT後特異性病因生存率局部

1.Impact of Local Control on Cause-Specific Survival After SBRT for Early-Stage NSCLC: Dynamic Prediction With Landmarking 對早期NSCLC關於SBRT後特異性病因生存率局部控製...[詳細]

T3N0M0型非小細胞肺癌切除術後的生存和預後

1.Survival and Prognostic Factors of Resected T3N0M0 NSCLC T3N0M0型非小細胞肺癌切除術後的生存和預後因素 Introduction 介紹 The 8thEdition T3N0M0 category represents a heter...[詳細]